A Food and Drug Administration official involved in scrutinizing the safety of antidepressants, COVID-19 vaccines and other widely used therapies is stepping down from her role leading the agency's drug program.
Dr. Tracy Beth Hoeg will be replaced as FDA's acting drug center director by Dr. Mike Davis, who has been serving as deputy director, according to an email sent to agency staff Friday that was obtained by the Associated Press.
